Nemolizumab-ilto: Revision history

15 April 2025

• curprev 01:2201:22, 15 April 2025 Parth Vikram Singh talk contribs 24,525 bytes +2 No edit summary

13 April 2025

• curprev 12:0812:08, 13 April 2025 Parth Vikram Singh talk contribs 24,523 bytes +1 No edit summary
• curprev 12:0412:04, 13 April 2025 Parth Vikram Singh talk contribs 24,522 bytes +1,693 No edit summary
• curprev 11:5611:56, 13 April 2025 Parth Vikram Singh talk contribs 22,829 bytes +4,572 No edit summary
• curprev 11:4211:42, 13 April 2025 Parth Vikram Singh talk contribs 18,257 bytes +8,768 No edit summary
• curprev 11:2311:23, 13 April 2025 Parth Vikram Singh talk contribs 9,489 bytes +4,628 No edit summary
• curprev 11:1011:10, 13 April 2025 Parth Vikram Singh talk contribs 4,861 bytes +2,797 No edit summary
• curprev 11:0111:01, 13 April 2025 Parth Vikram Singh talk contribs 2,064 bytes +131 No edit summary
• curprev 10:5910:59, 13 April 2025 Parth Vikram Singh talk contribs 1,933 bytes +824 No edit summary
• curprev 10:3610:36, 13 April 2025 Parth Vikram Singh talk contribs 1,109 bytes −10 No edit summary
• curprev 10:3410:34, 13 April 2025 Parth Vikram Singh talk contribs 1,119 bytes +145 No edit summary

12 April 2025

• curprev 13:4313:43, 12 April 2025 Parth Vikram Singh talk contribs 974 bytes +974 Created page with "{{DrugProjectFormSinglePage |authorTag={{PVS}} |indicationType=treatment |blackBoxWarningTitle='''<span style="color:#FF0000;">TITLE</span>''' |blackBoxWarningBody=''<span style="color:#FF0000;">Condition Name:</span>'' (Content) |offLabelAdultGuideSupport=There is limited information regarding ''Off-Label Guideline-Supported Use'' of Nemolizumab-ilto in adult patients. |offLabelAdultNoGuideSupport=There is limited information regarding ''Off-Label Non–Guideline-Suppor..."